TREATMENTS &
RESEARCH

Search the
latest
treatment
information
here.

Dr. Huntley's
Diagnosis
Checklist

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Bullous Pemphigoid » Treatments
 

Treatments for Bullous Pemphigoid

Treatments for Bullous Pemphigoid

The list of treatments mentioned in various sources for Bullous Pemphigoid includes the following list. Always seek professional medical advice about any treatment or change in treatment plans.

Bullous Pemphigoid: Is the Diagnosis Correct?

The first step in getting correct treatment is to get a correct diagnosis. Differential diagnosis list for Bullous Pemphigoid may include:

Bullous Pemphigoid: Marketplace Products, Discounts & Offers

Products, offers and promotion categories available for Bullous Pemphigoid:

Bullous Pemphigoid: Research Doctors & Specialists

Research all specialists including ratings, affiliations, and sanctions.

Unlabeled Drugs and Medications to treat Bullous Pemphigoid:

Unlabelled alternative drug treatments for Bullous Pemphigoid include:

  • Immune Globulin (intravenous)
  • Carimune
  • Carimune NF
  • Flebogamma
  • Gamimune N
  • Gammagard S/D
  • Gammar-P
  • Gamunex
  • Iveegam EN
  • Octagam
  • Panglobulin
  • Panglobulin NF
  • Polygam S/D
  • Iveegam Immuno
  • Cilax
  • Intacglobin
  • Sandoblobulina

Buy Products Related to Treatments for Bullous Pemphigoid

 
Shopping.com


Book Excerpts: Treatment of Bullous Pemphigoid

Treatments of Bullous Pemphigoid: Online Medical Books

16 MEDICAL BOOKS ONLINE! Review excerpts from medical books online, free, without registration, for more information about the treatments of Bullous Pemphigoid.

Vesicular & Bullous Lesions: Treatment
(In a Page: Signs and Symptoms)

  • HSV-1, HSV-2, and HZV can be effectively treated with antiviral medication (e.g., acyclovir, famciclovir). Early antiviral therapy may decrease the risk of post-herpetic neuralgia. HSV is infectious until all cutaneous lesions have crusted over
  • Bullous impetigo can be treated with topical mupirocin, or systemic antibiotics (e.g., erythromycin, cephalexin)
  • Dyshidrotic eczema can be difficult to treat. It is not curable, but can be controlled with high-potency topical steroid ointments and heavy emollients
  • PMLE is preventable with sun avoidance and zinc- or titanium-based sun blocks. Topical steroids can diminish the pruritus that accompanies an episode
  • SJS/TEN treatment consists of supportive care and discontinuing the offending drug, often requiring a burn center; IVIG and systemic steroids are sometimes used.
  • Systemic immunosuppressants (e.g., prednisone, cyclosporin, azathioprine) are often necessary to control autoimmune bullous diseases like pemphigus

» READ BOOK EXCERPT ONLINE »

Source: In a Page: Signs and Symptoms, 2004

Atopic dermatitis: Treatment
(Professional Guide to Diseases (Eighth Edition))

Measures to ease this chronic disorder include meticulous skin care, environmental control of offending allergens, and drug therapy. Because dry skin aggravates itching, frequent application of nonirritating topical lubricants is important, especially after bathing or showering. Minimizing exposure to allergens and irritants, such as wools and harsh detergents, also helps control symptoms.

Drug therapy involves corticosteroids and antipruritics. Active dermatitis responds well to topical corticosteroids, which should be applied immediately after bathing for optimal penetration. Oral antihistamines are commonly used to help control itching. A bedtime dose may reduce involuntary scratching during sleep. If secondary infection develops, antibiotics are necessary. A newer treatment is the use of topical immunomodulators; these agents are steroid-free and have demonstrated an 80% success rate in studies.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Dermatitis: Treatment
(Professional Guide to Diseases (Eighth Edition))

Effective treatment for atopic lesions consists of eliminating allergens and avoiding irritants, extreme temperature and humidity changes, and other precipitating factors; local and systemic measures relieve itching and inflammation. Antihistamines relieve itching and induce more restful sleep. Topical application of a corticosteroid ointment, especially after bathing, often alleviates inflammation. Between steroid doses, application of a moisturizing cream can help retain moisture. Systemic corticosteroid therapy should be used only during extreme exacerbations. Topical tacrolimus and pimecrolimus (an immunosuppressant known as a topical immunomodulator) are new agents used in patients older than age 2 who are intolerant of or unresponsive to conventional therapy. Weak tar preparations and ultraviolet B light therapy are used to increase the thickness of the stratum corneum. Antibiotics are appropriate if a bacterial agent has been cultured.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Dermatitis: Treatment
(Handbook of Diseases)

Effective treatment of atopic lesions consists of eliminating allergens and avoiding irritants (strong soaps, cleansers, and other chemicals), extreme temperature changes, and other precipitating factors. Local and systemic measures relieve itching and inflammation.

Clinical tip  Prevention of excessive dryness of the skin is critical to successful therapy.

Topical application of a cortico-steroid ointment, especially after bathing, usually alleviates inflammation. Between steroid doses, application of a moisturizing cream can help retain moisture. Systemic corticosteroid therapy should be used only during extreme exacerbations.

Weak tar preparations and ultraviolet B light therapy are used to increase the thickness of the stratum corneum. Antibiotics are appropriate for crusted and weeping lesions.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Cough - Case 4-2: 7-Week-Old Boy: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

As mentioned, infants with small VSDs usually do not require any intervention. They do require careful surveillance during the first 6 months of life, to assess growth and respiratory status. Many of these small VSDs close spontaneously. Importantly, these patients still require endocarditis prophylaxis.
Usually, those infants with moderate or large VSDs develop some degree of congestive heart failure. Medical management is often the initial therapy and may include furosemide, chlorothiazide, spironolactone, and digoxin. On occasion, afterload reduction with captopril is also required. In those patients with persistent failure to thrive, caloric augmentation may be required. If the patient 's congestive heart failure and growth failure are not controlled with medical management, surgical intervention is required.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003

Cough - Case 4-3: 7-Month-Old Girl: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

In uncomplicated measles, patients require only supportive care, including antipyretics and fluids. Antibiotics are necessary only in cases of bacterial superinfection, particularly pneumonia. Typical organisms causing a superinfected bacterial pneumonia include Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, and Streptococcus pyogenes.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003

Cough - Case 4-6: 4-Month-Old Boy: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

Because young infants with pertussis have a high risk for complications, there should be a low threshold for admitting these patients. Many of these infants require admission to the intensive care unit to monitor for apneic episodes and neurologic sequelae.
Infants should be treated with a macrolide antibiotic, and erythromycin is the most common choice. The length of therapy is generally recommended to be 14 days. Azithromycin and clarithromycin appear to be effective as well. There is some controversy as to whether antibiotics given during the catarrhal stage decrease disease severity. However, antibiotics should still be given, even in the paroxysmal stage, because they limit the spread of the disease to others. Studies are underway to assess the efficacy of pertussis immune globulin as an adjunctive therapy in extremely ill infants.
Antibiotic prophylaxis is recommended for all household members and close contacts and usually consists of 10 to 14 days of erythromycin. Prevention is essential to limit the morbidity and mortality from pertussis, and the acellular pertussis vaccine is currently the recommended form. It is given in combination with diphtheria and tetanus toxoids (DTaP). It is recommended that children receive five doses before school entry.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003

Diarrhea - Case 17-1: 2-Month-Old Boy: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

In cases of incarcerated hernia, time is of the essence. Compromised blood flow to the affected loop of bowel can result in strangulation and bowel necrosis within 2 hours, so medical intervention is necessary. Reduction of the incarcerated hernia by experienced pediatric surgical staff is optimal. A gentle attempt at reduction using pressure on the scrotum with simultaneous counterpressure above the external inguinal ring is indicated but should never be forcefully done. Intravenous hydration and nasogastric tube decompression, in anticipation of definitive surgical management, are also indicated. Emergency surgery is sometimes required if the incarcerated hernia is not reducible. If the incarcerated loop of bowel is reduced, surgery may be postponed 12 to 36 hours so that the bowel edema can resolve.
Elective repair of an asymptomatic inguinal hernia should be performed as soon as possible after diagnosis, to avoid complications such as incarceration. All inguinal hernias require surgical intervention, because they do not resolve spontaneously. In boys, undescended testes may be associated with inguinal hernia, requiring orchiopexy. There is still some debate as to the importance of surgical exploration of the contralateral side in search of an occult inguinal hernia not detected by physical examination, as was the case in this patient. This decision is left to the individual surgeon, but contralateral exploration is commonly performed.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003

Diarrhea - Case 17-4: 15-Month-Old Boy: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

Surgical resection is usually performed. Low-risk patients may not need any additional therapy. Radiotherapy and chemotherapy are used, depending on the stage of the disease. Patients with high-risk disease may have some improvement in short-term survival with autologous bone marrow transplantation, but longer-term outcome is still poor. Surgical removal of the tumor usually cures the secretory diarrhea. The use of somatostatin analogues also has a therapeutic effect on the secretory diarrhea, but the definitive therapy for the diarrhea remains surgical.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003

Fever - Case 11-1: 18-Month-Old Girl: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

No specific therapy is currently available. In the future, targeted therapies for NF1-associated tumors may be designed to inhibit growth-promoting pathways activated in the absence of neurofibromin. Other potential therapies focus on blockade of angiogenic factors that could potentially decrease tumor growth.
Routine office visits should focus on detection and management of complications, as discussed previously. Annual ophthalmologic examinations are important to detect optic nerve lesions. Interval history should focus on subtle sensory or motor symptoms such as paresthesia or muscle atrophy. Pediatricians should also inquire about incontinence, given the risk of spinal cord neurofibromas. Consultation with specific surgical specialists is warranted based on the location of neurofibromas. Laser treatment has not yet proved successful in permanently removing caf é-au-lait spots.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003

Fever - Case 11-4: 7-Month-Old Girl: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

Most patients require only appropriate antibiotic therapy to treat bacterial infections as they occur. Prophylactic antibiotics are not routinely used, because the efficacy of such prophylaxis is unclear. Some patients benefit from antibacterial mouthwashes for occasional mouth sores and gingivitis. G-CSF, corticosteroids, and intravenous gammaglobulin administration are not routinely required but have been used to increase neutrophil counts in patients with serious or recurrent infections (15% of patients with AIN in infancy). In such cases, approximately 50% of children respond to corticosteroids and 75% respond to gammaglobulin. G-CSF is effective in almost all patients. The neutropenia resolves spontaneously in 95% of patients, usually within 7 to 24 months. Disappearance of autoantibodies precedes spontaneous normalization of the neutrophil count.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003

Jaundice - Case 15-1: 14-Day-Old Boy: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

The removal of galactose from the diet remains the first principle of therapy for galactosemia. The exclusion of milk (including breast milk) and dairy products is necessary for the patient 's lifetime.
Depending on the degree of illness at the time of presentation, galactosemic neonates often require supportive care measures such as intravenous fluids and antibiotics. Liver synthetic function may be compromised, and the sick infant may require supplemental vitamin K or even transfusion of fresh-frozen plasma.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003

Jaundice - Case 15-3: 2-Month-Old Boy: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

Replacement of the hormones produced by the pituitary's target organs is the cornerstone of hypopituitarism therapy. Thyroid hormone replacement should begin as soon as confirmatory testing is completed; delays in therapy can result in increased risk of cognitive impairment. Jaundice improves as the underlying endocrine disorder is treated.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003

Jaundice - Case 15-4: 6-Week-Old Girl: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

The hepatic portoenterostomy (Kasai procedure) for biliary atresia involves the anastomosis of a limb of small intestine to hepatic ducts in the region of the porta hepatis (where the portal vein and hepatic artery enter the liver and the hepatic ducts exit). It relies on the patency of tiny duct remnants to allow for bile drainage from the liver. Cholangitis is among the most worrisome of the postoperative complications of hepatic portoenterostomy; its signs and symptoms include fever, diminished bile flow, and the return of hyperbilirubinemia. Over time, survivors of hepatic portoenterostomy are also at risk for liver dysfunction, portal hypertension, esophageal varices, hypersplenism, and hepatopulmonary syndrome, in which arteriovenous shunts form within the lung. Liver transplantation is often required for patients who have undergone portoenterostomy for EHBA, and it is sometimes necessary as a primary operation if liver disease is far advanced at the time of diagnosis. Estimates of 10-year survival for patients with EHBA range from 40% to 70%. Approximately 25% to 40% of patients survive 10 years without requiring transplantation.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003

Jaundice - Case 15-6: 5-Week-Old Girl: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

Treatment of Alagille syndrome focuses on the medical management of cholestasis, promotion of growth and development, and treatment of any comorbidities (e.g., congenital heart disease). Children with Alagille syndrome suffer from malabsorption and require supplementation of fat-soluble vitamins and provision of sufficient calories for growth, which may necessitate tube feeding. Infants should receive formulas containing medium-chain triglycerides, which are absorbable without bile salts. Medications that may benefit Alagille patients (for example, by promoting bile flow or reducing pruritus) include phenobarbital, cholestyramine, ursodeoxycholic acid, and antihistamines.
Long-term follow-up of patients with Alagille syndrome includes monitoring for the development of cirrhosis, portal hypertension, ascites, and liver failure. The 20-year life expectancy for patients with Alagille syndrome is about 75% overall, although rates are lower for those patients who require liver transplantation and for those with severe associated abnormalities (e.g., congenital heart disease).

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003

Pallor - Case 10-1: 3-Week-Old Boy: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

The treatment includes use of corticosteroids. The currently recommended dose is 2 mg/kg per day of prednisone, given in three or four divided doses. Reticulocytes appear within 1 to 2 weeks, but the rise in hemoglobin is delayed for several more weeks. Once the hemoglobin level reaches 10 g/dL, the steroid dose is gradually tapered until the patient is receiving a single daily dose that adequately maintains appropriate hemoglobin levels. Response followed by steroid dependence is seen in 60% of patients. Approximately one fifth of the steroid-responsive patients may ultimately be maintained without steroids.
Approximately 30% to 40% of patients have poor or no response to steroids and require chronic transfusion therapy to maintain normal hemoglobin. These children require leukocyte-depleted packed RBC transfusions every 3 to 6 weeks, with the goal of keeping the hemoglobin level higher than 6 g/dL. Concurrent chelation of iron with subcutaneously administered desferrioxamine may decrease some chronic transfusion-related complications. Complications of chronic transfusion therapy are similar to those seen with other conditions that employ this modality (e.g., thalassemia). Bone marrow transplantation has been successful for some patients.
Median survival time is 43 years, but approximately 13% of patients die within the first 6 years of life. Deaths occur from complications of iron overload, pneumonia, sepsis, and occasionally transplant-related complications, leukemia, and pulmonary emboli.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003

Pallor - Case 10-2: 12-Month-Old Girl: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

Treatment of iron deficiency depends on its cause. For children with suspected dietary deficiency, treatment consists of supplemental iron. In children with anemia, an initial therapeutic trial often eliminates the need for expensive laboratory testing in determining the diagnosis. The reticulocyte count usually increases within several days and the hemoglobin concentration within 3 weeks. Patients should be treated until the hemoglobin reaches the normal range and then for at least one additional month to replete the iron stores. Failure of the hemoglobin level to rise within 1 month indicates either poor compliance with iron therapy or incorrect diagnosis.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003

Pallor - Case 10-3: 5-Month-Old Boy: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

The mainstay of treatment is corticosteroids, given at a dosage of 2 to 10 mg/kg per day. In severely ill patients such as this child, the steroids should be given intravenously. Otherwise, the care is supportive and includes replacement therapy. Compatible cross-matching may not be possible, but if the patient is in extremis blood type group O, Rh-negative blood should be used in aliquots that are given slowly and in amounts sufficient to stabilize the cardiovascular system. The patient should be adequately hydrated to avoid renal involvement. Splenectomy may be necessary if steroid therapy fails.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003

Rash - Case 9-2: 7-Week-Old Girl: VI. Treatment
(Pediatric Complaints and Diagnostic Dilemmas)

The injuries suffered by the child should be managed as medically indicated. The state division of child and family services should be notified in all cases of suspected abuse. Removal from the home and placement in foster care may be required. In this case, once the child was removed from the home, no additional lesions were noted.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Complaints and Diagnostic Dilemmas, 2003



 » Next page: Alternative Treatments for Bullous Pemphigoid

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Next articles:

Tools & Services:

Medical Articles:

Forums & Message Boards

 
HONcode We subscribe to the HONcode principles

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise